Management

According to GBI Research, there are 112 first-in-class programmes in the head and neck cancer pipeline, acting on 87 distinct…

Chinmoy Roy, Data Integrity SME, US and Arjun Guha Thakurta, Director, Life Science Consulting, a ConvalGroup Company, India,…

Implementation of a state programme to improve the healthcare industry has also had a positive impact on domestic production

The market is set to decline from $35.5 bn in 2017 to $34.16 bn in 2021

Increased regulatory scrutiny and consolidation of supply chain in the US market resulting in pricing pressures along with…

Shailly Gupta, Deputy Head, MSF Access Campaign (India) emphaises the need to ensure availability of affordable medicines within…

The 9th edition of Marsh India’s Employee Health & Benefits Survey analyses both employer and employee perspectives, to gain a…

According to GBI research Ocrelizumab is expected to become a blockbuster drug within three years of its launch and will be…

GlobalData forecasts all inhibitors to collectively produce sales of $4.8 billion by 2023 in the US, Spain, UK, Italy, Germany,…

Bouyed up with promising research results, Glenmark seems to be revving up for some major out-licensing deals. Do they finally…